Synergistic combination of N-acetylcysteine and ribavirin to protect from lethal influenza viral infection in a mouse model
about
Inflammatory and oxidative stress in rotavirus infectionModulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory DrugsCompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusN-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infectionCombination chemotherapy for influenza.N-acetylcysteine lacks universal inhibitory activity against influenza A viruses.Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation.Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation.Inhibition of rotavirus ECwt infection in ICR suckling mice by N-acetylcysteine, peroxisome proliferator-activated receptor gamma agonists and cyclooxygenase-2 inhibitors.Role of glutathione in immunity and inflammation in the lung.Intracellular redox state as target for anti-influenza therapy: are antioxidants always effective?Combinations of 1,8-cineol and oseltamivir for the treatment of influenza virus A (H3N2) infection in mice.Virus-inhibiting activity of dihydroquercetin, a flavonoid from Larix sibirica, against coxsackievirus B4 in a model of viral pancreatitis.Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase.A scavenger role for nitric oxide in the aged rat kidney.Excessively high magnetic resonance signal in preterm infants and neuropsychobehavioural follow-up at 2 years.Redox Biology of Respiratory Viral Infections
P2860
Q26749801-36C537EB-29B9-4B66-9D35-5DF047C13B25Q26800158-717A86D6-AF6D-4A05-91A5-CFC4DE8DDF82Q28084005-8F664966-B17D-4CC5-9D93-B363389EF433Q28236065-FA483F7E-E512-4EA4-96C2-19EECCFA8380Q30408112-AED66785-2B78-47C1-97E5-391CFDA1E271Q35014574-FB807A28-D449-4B4B-8EEF-859F873CF269Q37110768-9AEFFC9D-ED2C-43BF-91ED-428D20D9BBFDQ37410985-3CF0D61D-3E99-4E50-8F5F-F4E14502BA44Q37675315-EDB3A794-47D1-41C6-90D7-1B260929341EQ37853027-4E7E7CC4-2033-41F0-A7B2-20E6E4171C60Q38283718-AC90A293-9945-430F-B95A-F616806AB881Q39102455-FB301496-F3B6-4C15-8E4E-B95337EBFF10Q40968334-5595A324-F03D-4235-9725-77FF9900BC34Q43181823-25823BA7-C60E-4D75-966A-92B79919801DQ45088419-E568A95C-4809-4502-A39D-14B90E389162Q48890573-337B5689-A7BE-4E77-9EFF-558159869B42Q56967921-7F16456C-7138-487A-8C46-84A2125C3EB4
P2860
Synergistic combination of N-acetylcysteine and ribavirin to protect from lethal influenza viral infection in a mouse model
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Synergistic combination of N-a ...... ral infection in a mouse model
@ast
Synergistic combination of N-a ...... ral infection in a mouse model
@en
Synergistic combination of N-a ...... ral infection in a mouse model
@nl
type
label
Synergistic combination of N-a ...... ral infection in a mouse model
@ast
Synergistic combination of N-a ...... ral infection in a mouse model
@en
Synergistic combination of N-a ...... ral infection in a mouse model
@nl
prefLabel
Synergistic combination of N-a ...... ral infection in a mouse model
@ast
Synergistic combination of N-a ...... ral infection in a mouse model
@en
Synergistic combination of N-a ...... ral infection in a mouse model
@nl
P2860
P1476
Synergistic combination of N-a ...... ral infection in a mouse model
@en
P2093
P2860
P304
P356
10.1177/039463200401700114
P407
P577
2004-01-01T00:00:00Z